New anti-viral composition effective in combating influenza A viruses
Scientists
have developed a unique anti-viral composition that can effectively provide
protection against several influenza
A viruses such as H1N1, H3N2, H5N1 and H7N9.
Influenza,
a contagious respiratory illness that infects the nose, throat and lungs, is
among the leading causes of death, according to the Centres for Disease Control
and Prevention.
The
new anti-viral
composition is made up of three siRNAs (small interfering ribonucleic
acids) targeted at three genes and encapsulated in hybrid polyelectrolyte microcapsules,
the Sputnik reported.
The
results will be used to develop a drug to prevent and treat the viral
infection, according to Alexander Timin from the Tomsk Polytechnic University
in Russia.
The
team developed 11 new siRNAs with anti-viral activity in vitro that can
suppress conserved and consensus sequences in the genome of the influenza A virus
on the NS, PA and NP genes.
Anti-viral
properties were screened and three siRNAs -- PA-1630, NP-717 and NS-777 -- were
selected for their most pronounced inhibitory ability, the report said. Read
More
Comments
Post a Comment